References

Stress fractures: current concepts

10.2214/ajr.159.2.1632335 · 1992 · External reference

Physical Injury: Concepts and Terminology

1995 · External reference

Pagets Disease

1995 · External reference

The pathophysiology of osteoporotic hip fracture

2008 · External reference

An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?

10.1016/j.injury.2007.08.036 · 2008 · External reference

Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution

10.1302/0301-620x.89b3.18146 · 2007 · External reference

Fractures of the hip

2002 · External reference

Subtrochanteric stress fractures in runners

10.1177/036354658201000407 · 1982 · External reference

A displaced subtrochanteric stress fracture in a young amenorrheic athlete

10.1177/036354659202000425 · 1992 · External reference

Severely suppressed bone turnover: a potential complication of alendronate therapy

10.1210/jc.2004-0952 · 2005 · External reference

Low-energy femoral shaft fractures associated with alendronate use

10.1097/bot.0b013e318172841c · 2008 · External reference

Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate

10.1056/nejmc0707493 · 2008 · External reference

Reports of adverse events from bone drugs prompt caution

10.1001/jama.295.24.2833 · 2006 · External reference

Long-term safety of bisphosphonates

10.1210/jc.2005-0057 · 2005 · External reference

Unresolved reference

External reference

Alendronate has a residual effect on bone mass in postmenopausal Danish women up to 7 years after treatment withdrawal

10.1016/s8756-3282(03)00112-1 · 2003 · External reference

Increments in bone mineral density of the lumbar spine and hip and suppression of bone turnover are maintained after discontinuation of alendronate in postmenopausal women

10.1016/s0002-9343(97)00130-7 · 1997 · External reference